Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Phage therapy: From biological mechanisms to future directions
Steffanie A. Strathdee, Graham F. Hatfull, Vivek K. Mutalik, et al.
Cell (2023) Vol. 186, Iss. 1, pp. 17-31
Open Access | Times Cited: 347

Showing 1-25 of 347 citing articles:

Current Clinical Landscape and Global Potential of Bacteriophage Therapy
Nicole Hitchcock, Danielle Devequi Gomes Nunes, Job Shiach, et al.
Viruses (2023) Vol. 15, Iss. 4, pp. 1020-1020
Open Access | Times Cited: 82
Gut liver brain axis in diseases: the implications for therapeutic interventions
Mengyao Yan, Shuli Man, Benyue Sun, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 72
Translating phage therapy into the clinic: Recent accomplishments but continuing challenges
Aleksandra Petrović Fabijan, Jonathan R. Iredell, Katarzyna Danis‐Wlodarczyk, et al.
PLoS Biology (2023) Vol. 21, Iss. 5, pp. e3002119-e3002119
Open Access | Times Cited: 61
Phage Therapy—Challenges, Opportunities and Future Prospects
Beata Zalewska-Pia̧tek
Pharmaceuticals (2023) Vol. 16, Iss. 12, pp. 1638-1638
Open Access | Times Cited: 56
Bacterial persisters: molecular mechanisms and therapeutic development
Hongxia Niu, Jiaying Gu, Ying Zhang
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 44
Positive and negative aspects of bacteriophages and their immense role in the food chain
Soniya Ranveer, Vaishali Dasriya, Md Faruque Ahmad, et al.
npj Science of Food (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 40
Topical phage therapy in a mouse model of Cutibacterium acnes-induced acne-like lesions
Amit Rimon, Chani Rakov, Vanda Lerer, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 39
Expanding antibiotic, vaccine, and diagnostics development and access to tackle antimicrobial resistance
Ramanan Laxminarayan, Isabella Impalli, Radha Rangarajan, et al.
The Lancet (2024) Vol. 403, Iss. 10443, pp. 2534-2550
Closed Access | Times Cited: 34
Antimicrobial resistance crisis: could artificial intelligence be the solution?
Guangyu Liu, Dan Yu, Mei-Mei Fan, et al.
Military Medical Research (2024) Vol. 11, Iss. 1
Open Access | Times Cited: 29
Bacteriophage therapy for drug-resistant Staphylococcus aureus infections
Kaixin Liu, Chao Wang, Xudong Zhou, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 19
The Medicinal Phage—Regulatory Roadmap for Phage Therapy under EU Pharmaceutical Legislation
Timo Faltus
Viruses (2024) Vol. 16, Iss. 3, pp. 443-443
Open Access | Times Cited: 15
Advanced application of slightly acidic electrolyzed water for fresh-cut fruits and vegetables preservation
Yanlin Du, Qi Tian, Guijing Li, et al.
Food Research International (2024) Vol. 195, pp. 114996-114996
Closed Access | Times Cited: 15
Prediction of strain level phage–host interactions across the Escherichia genus using only genomic information
Baptiste Gaborieau, Hugo Vaysset, Florian Tesson, et al.
Nature Microbiology (2024) Vol. 9, Iss. 11, pp. 2847-2861
Closed Access | Times Cited: 15
Staphylococcus haemolyticus: An updated review on nosocomial infections, antimicrobial resistance, virulence, genetic traits, and strategies for combating this emerging opportunistic pathogen
Ciro César Rossi, Faizan Ahmad, Marcia Giambiagi‐deMarval
Microbiological Research (2024) Vol. 282, pp. 127652-127652
Closed Access | Times Cited: 14
Engineered Bacteriophage-Based In Situ Vaccine Remodels a Tumor Microenvironment and Elicits Potent Antitumor Immunity
Lei Lei, Jiayao Yan, Kai Xin, et al.
ACS Nano (2024) Vol. 18, Iss. 19, pp. 12194-12209
Closed Access | Times Cited: 14
Probiotic biofilm modified scaffolds for facilitating osteomyelitis treatment through sustained release of bacteriophage and regulated macrophage polarization
Junwei Su, Yifan Wu, Zheng Wang, et al.
Materials Today Bio (2025) Vol. 30, pp. 101444-101444
Closed Access | Times Cited: 1
Bacteriophage Adsorption: Likelihood of Virion Encounter with Bacteria and Other Factors Affecting Rates
Stephen T. Abedon
Antibiotics (2023) Vol. 12, Iss. 4, pp. 723-723
Open Access | Times Cited: 30
The mechanism of the phage-encoded protein antibiotic from ΦX174
Anna K. Orta, Nadia Riera, Yancheng E. Li, et al.
Science (2023) Vol. 381, Iss. 6654
Closed Access | Times Cited: 22
Refractory Pseudomonas aeruginosa infections treated with phage PASA16: A compassionate use case series
Hadil Onallah, Ronen Hazan, Ran Nir‐Paz, et al.
Med (2023) Vol. 4, Iss. 9, pp. 600-611.e4
Closed Access | Times Cited: 22
Bioprospecting the Skin Microbiome: Advances in Therapeutics and Personal Care Products
Keir Nicholas-Haizelden, Barry Murphy, Michael Hoptroff, et al.
Microorganisms (2023) Vol. 11, Iss. 8, pp. 1899-1899
Open Access | Times Cited: 21
Current Knowledge and Perspectives of Phage Therapy for Combating Refractory Wound Infections
Bo Wang, Lin Du, Baiping Dong, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5465-5465
Open Access | Times Cited: 13
CRISPR-Cas in Pseudomonas aeruginosa provides transient population-level immunity against high phage exposures
Bridget N. J. Watson, Loris Capria, Ellinor Alseth, et al.
The ISME Journal (2024) Vol. 18, Iss. 1
Open Access | Times Cited: 11
A Comprehensive Review on Phage Therapy and Phage-Based Drug Development
Longzhu Cui, Shinya Watanabe, Kazuhiko Miyanaga, et al.
Antibiotics (2024) Vol. 13, Iss. 9, pp. 870-870
Open Access | Times Cited: 11
Therapeutic Potential of a Novel Lytic Phage, vB_EclM_ECLFM1, against Carbapenem-Resistant Enterobacter cloacae
Saieeda Fabia Ali, Soon-Hian Teh, Hsueh‐Hui Yang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 854-854
Open Access | Times Cited: 10
Guiding antibiotics towards their target using bacteriophage proteins
Xinghong Zhao, Xinyi Zhong, Shinong Yang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top